戴 承正

Medicine & Life Sciences

1. Solanum nigrum 100%
2. Cellular Apoptosis Susceptibility Protein 87%
3. Neoplasms 80%
4. Breast Neoplasms 72%
5. Drug Therapy 67%
6. Cisplatin 64%
7. glucose-regulated proteins 55%
8. Hepatocellular Carcinoma 55%
9. Colorectal Neoplasms 52%
10. Docetaxel 48%
11. Doxorubicin 46%
12. Fluorouracil 41%
13. Neoplasm Metastasis 38%
14. Therapeutics 36%
15. Avemar 32%
16. Salvage Therapy 30%
17. Chromosome Segregation 30%
18. Epithelial-Mesenchymal Transition 30%
19. Carcinoma 29%
20. Apoptosis 29%
21. Bevacizumab 26%
22. Cell Death 26%
23. SERPIN-B5 25%
24. Autophagy 23%
25. Ovarian Neoplasms 22%
26. Thrombomodulin 21%
27. Camptothecin 21%
28. Pancreatic Neoplasms 20%
29. Hep G2 Cells 20%
30. gemcitabine 20%
31. Cetuximab 20%
32. Sorafenib 19%
33. Paris 19%
34. Yang Deficiency 19%
35. Chinese Traditional Medicine 19%
36. Oxaliplatin 18%
37. Extracellular Signal-Regulated MAP Kinases 18%
38. 6-dehydrogingerdione 18%
39. Curcumin 18%
40. Quality of Life 18%
41. Complementary Therapies 17%
42. PPAR gamma 17%
43. Staining and Labeling 17%
44. Endometrial Neoplasms 17%
45. Oncolytic Viruses 17%
46. Measles virus 16%
47. Hepacivirus 16%
48. Pharmaceutical Preparations 16%
49. Rectal Neoplasms 16%
50. pardaxin 16%